nach oben

Supportive Care in Cancer

Erschienen in:

29.03.2019 | Original Article

How communication between cancer patients and their specialists affect the quality and cost of cancer care

verfasst von: Neli Slavova-Azmanova, Jade C. Newton, Harry Hohnen, Claire E. Johnson, Christobel Saunders

Erschienen in: Supportive Care in Cancer | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Communication in cancer care is multidimensional and may affect patient treatment decision-making and quality of life. This study examined cancer patients’ perceptions of the communication with their cancer specialists and explored its impact on the care they received and the financial burden they experienced.

Methods

Semi-structured telephone interviews were conducted with 20 rural and 20 outer metropolitan Western Australians diagnosed with breast, lung, prostate or colorectal cancer. Thematic analysis using a phenomenological approach was undertaken to derive key themes regarding the communication experiences of the participants.

Results

Four main themes emerged: information context, communication about treatment options and treatment providers, communication about costs of treatment and impact of communication on continuity of care. The quality of the communication experienced by participants was variable and in many cases sub-optimal. This affected their ability to undertake well-informed decisions regarding treatment and providers and led to substantial out-of-pocket expenses for several participants. Whilst participants differed in their information needs and expectations, most participants trusted clinicians’ treatment recommendations.

Conclusions

Our results raise concerns about the quality of communication cancer patients receive during treatment and the repercussions for their treatment decisions and out-of-pocket expenses. Clear treatment and cost communication could empower patients in choosing treatment and providers. However, these findings suggest patients must remain vigilant during consultations and discuss available treatment pathways and their financial dimension to avoid costly treatments or missing out on available financial aid.

Street RL Jr, Makoul G, Arora NK, Epstein RM (2009) How does communication heal? Pathways linking clinician-patient communication to health outcomes. Patient Educ Couns 74(3):295–301. https://doi.org/10.1016/j.pec.2008.11.015 CrossRefPubMed

Epstein RM, Street RL, Jr (2007) Patient-centered communication in cancer care: promoting healing and reducing suffering https://healthcaredelivery.cancer.gov/pcc/monograph.html. Accessed 4 May 2016

Johansen NJ, Saunders CM (2017) Value-based care in the worldwide battle against cancer. Cureus 9(2):e1039. https://doi.org/10.7759/cureus.1039 CrossRefPubMedPubMedCentral

Thorne SE, Bultz BD, Baile WF (2005) Is there a cost to poor communication in cancer care?: a critical review of the literature. Psychooncology 14(10):875–884; discussion 885-876. https://doi.org/10.1002/pon.947 CrossRefPubMed

Prouty CD, Mazor KM, Greene SM, Roblin DW, Firneno CL, Lemay CA, Robinson BE, Gallagher TH (2014) Providers’ perceptions of communication breakdowns in cancer care. J Gen Intern Med 29(8):1122–1130. https://doi.org/10.1007/s11606-014-2769-1 CrossRefPubMedPubMedCentral

Ubel PA, Abernethy AP, Zafar SY (2013) Full disclosure—out-of-pocket costs as side effects. N Engl J Med 369(16):1484–1486. https://doi.org/10.1056/NEJMp1306826 CrossRefPubMed

Ramsey SD, Bansal A, Fedorenko CR, Blough DK, Overstreet KA, Shankaran V, Newcomb P (2016) Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol 34(9):980–986. https://doi.org/10.1200/JCO.2015.64.6620 CrossRefPubMedPubMedCentral

PDQ Adult Treatment Editorial Board (2017) Financial toxicity (financial distress) and cancer treatment (PDQ®): patient version. National Cancer Institute (US) https://www.ncbi.nlm.nih.gov/books/NBK441635/. Accessed 24 Aug 2018

Australian Institute of Health and Welfare (2017) Cancer in Australia 2017. Cancer series no. 101. Cat. no. CAN 100. AIHW. https://www.aihw.gov.au/reports/cancer/cancer-in-australia-2017/contents/table-of-contents. Accessed 18 May 2017

10.

Australian Institute of Health and Welfare (2017) Health expenditure Australia 2015–16. Health and welfare expenditure series no. 58. Cat. no. HWE 68. AIHW. https://www.aihw.gov.au/reports/health-welfare-expenditure/health-expenditure-australia-2015-16/data. Accessed 20 Nov 2017

11.

Consumers Health Forum of Australia (2018) Out of pocket pain research report. https://chf.org.au/sites/default/files/20180404_oop_report.pdf. Accessed 12 April 2018

12.

Economics DA (2017) Financial impacts of breast cancer in Australia. Deliotte. https://www2.deloitte.com/au/en/pages/economics/articles/financial-impact-breast-cancer-australia.html. Accessed 27 Sept 2017

13.

Gordon LG, Beesley VL, Mihala G, Koczwara B, Lynch BM (2017) Reduced employment and financial hardship among middle-aged individuals with colorectal cancer. Eur J Cancer Care 26(5). https://doi.org/10.1111/ecc.12744

14.

Gordon LG, Walker SM, Mervin MC, Lowe A, Smith DP, Gardiner RA, Chambers SK (2017) Financial toxicity: a potential side effect of prostate cancer treatment among Australian men. European Journal of Cancer Care. https://doi.org/10.1111/ecc.12392

15.

Shih YT, Chien CR (2017) A review of cost communication in oncology: patient attitude, provider acceptance, and outcome assessment. Cancer 123(6):928–939. https://doi.org/10.1002/cncr.30423 CrossRefPubMed

16.

Hamel LM, Penner LA, Eggly S, Chapman R, Klamerus JF, Simon MS, Stanton SC, Albrecht TL (2017) Do patients and oncologists discuss the cost of cancer treatment? An observational study of clinical interactions between African American patients and their oncologists. J Oncol Pract 13(3):e249–e258. https://doi.org/10.1200/JOP.2016.015859 CrossRefPubMed

17.

Kim P (2007) Cost of cancer care: the patient perspective. J Clin Oncol 25(2):228–232. https://doi.org/10.1200/JCO.2006.07.9111 CrossRefPubMed

18.

Kelly RJ, Forde PM, Elnahal SM, Forastiere AA, Rosner GL, Smith TJ (2015) Patients and physicians can discuss costs of cancer treatment in the clinic. J Oncol Pract 11(4):308–312. https://doi.org/10.1200/JOP.2015.003780 CrossRefPubMedPubMedCentral

19.

Bullock AJ, Hofstatter EW, Yushak ML, Buss MK (2012) Understanding patients’ attitudes toward communication about the cost of cancer care. J Oncol Pract 8(4):e50–e58. https://doi.org/10.1200/JOP.2011.000418 CrossRefPubMedPubMedCentral

20.

Breast Cancer Network Australia (2018) State of the nation report. https://www.bcna.org.au/media/6656/sotn-report-lowres.pdf. Accessed 15 Jun 2018

21.

Australian Bureau of Statistics (2017) 3101.0—Australian Demographic Statistics, Sep 2017. Australian Bureau of Statistics. http://www.abs.gov.au/ausstats/abs@.nsf/PrimaryMainFeatures/3101.0?OpenDocument. Accessed 1 May 2018

22.

Australian Bureau of Statistics (2013) 4364.0.55.002—Australian Health Survey: health service usage and health related actions, 2011–12. http://www.abs.gov.au/ausstats/abs@.nsf/lookup/E334D0A98272E4DCCA257B39000F2DCF. Accessed 1 May 2018

23.

Newton JC, Johnson CE, Hohnen H, Bulsara M, Ives A, McKiernan S, Platt V, McConigley R, Slavova-Azmanova NS, Saunders C (2018) Out-of-pocket expenses experienced by rural Western Australians diagnosed with cancer. Support Care Cancer 26:3543–3552. https://doi.org/10.1007/s00520-018-4205-2 CrossRefPubMed

24.

Creswell JW (2007) Qualitative inquiry & research design: choosing among five approaches / John W. Creswell. Qualitative inquiry and research design. Sage Publications, Thousand Oaks

25.

Morse JM (1994) Designing funded qualitative research

26.

Given LM (2008) The Sage encyclopedia of qualitative research methods. Sage publications, Thousand OaksCrossRef

27.

Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3(2):77–101CrossRef

28.

Cancer Council Australia (2014) Ideal oncology curriculum—communication skills—communication and counselling. Cancer Council Australia. https://wiki.cancer.org.au/oncologyformedicalstudents_mw/index.php?oldid=1590. Accessed 17 April 2018

29.

National Cancer Institute (2018) Communication in Cancer Care (PDQ®)–health professional version. https://www.cancer.gov/about-cancer/coping/adjusting-to-cancer/communication-hp-pdq. Accessed 17 April 2018

30.

Cancer Council Victoria Victorian Cancer Clinicians Communication Program. https://www.cancervic.org.au/for-health-professionals/training-education/vcccp. Accessed 19 November 2018 2018

31.

Cancer Australia Communication skills training https://canceraustralia.gov.au/clinical-best-practice/cancer-learning/communication-skills-training. Accessed 19 Nov 2018 2018

32.

van Dongen JJJ, de Wit M, Smeets HWH, Stoffers E, van Bokhoven MA, Daniels R (2017) “They are talking about me, but not with me”: a focus group study to explore the patient perspective on Interprofessional team meetings in primary care. Patient 10(4):429–438. https://doi.org/10.1007/s40271-017-0214-3 CrossRefPubMedPubMedCentral

33.

Rocque R, Leanza Y (2015) A systematic review of patients’ experiences in communicating with primary care physicians: intercultural encounters and a balance between vulnerability and integrity. PLoS One 10(10):e0139577. https://doi.org/10.1371/journal.pone.0139577 CrossRefPubMedPubMedCentral

34.

Nekhlyudov L, Levit L, Hurria A, Ganz PA (2014) Patient-centered, evidence-based, and cost-conscious cancer care across the continuum: translating the Institute of Medicine report into clinical practice. CA Cancer J Clin 64(6):408–421. https://doi.org/10.3322/caac.21249 CrossRefPubMed

35.

Sullivan R, Peppercorn J, Sikora K, Zalcberg J, Meropol NJ, Amir E, Khayat D, Boyle P, Autier P, Tannock IF, Fojo T, Siderov J, Williamson S, Camporesi S, McVie JG, Purushotham AD, Naredi P, Eggermont A, Brennan MF, Steinberg ML, De Ridder M, McCloskey SA, Verellen D, Roberts T, Storme G, Hicks RJ, Ell PJ, Hirsch BR, Carbone DP, Schulman KA, Catchpole P, Taylor D, Geissler J, Brinker NG, Meltzer D, Kerr D, Aapro M (2011) Delivering affordable cancer care in high-income countries. Lancet Oncol 12(10):933–980. https://doi.org/10.1016/S1470-2045(11)70141-3 CrossRefPubMed

36.

Salmon P, Young B (2017) A new paradigm for clinical communication: critical review of literature in cancer care. Med Educ 51(3):258–268. https://doi.org/10.1111/medu.13204 CrossRefPubMed

37.

Doyle C, Lennox L, Bell D (2013) A systematic review of evidence on the links between patient experience and clinical safety and effectiveness. BMJ Open 3(1):e001570. https://doi.org/10.1136/bmjopen-2012-001570 CrossRefPubMedPubMedCentral

38.

Wollins DS, Zafar SY (2016) A touchy subject: can physicians improve value by discussing costs and clinical benefits with patients? Oncologist 21(10):1157–1160. https://doi.org/10.1634/theoncologist.2016-0207 CrossRefPubMedPubMedCentral

39.

Australian Government Department of Health (2018) Optimal cancer care pathways (OCPs). http://www.health.gov.au/internet/main/publishing.nsf/content/occp. Accessed June 2018 2018

40.

Porter ME, Larsson S, Lee TH (2016) Standardizing patient outcomes measurement. N Engl J Med 374(6):504–506. https://doi.org/10.1056/NEJMp1511701 CrossRefPubMed

41.

Porter ME, Lee TH (2013) The strategy that will fix health care. Harv Bus Rev 91(10):1–9

42.

Abrahams E, Balch A, Goldsmith P, Kean M, Miller AM, Omenn G, Sonet E, Sprandio J, Tyne C, Westrich K (2017) Clinical pathways: recommendations for putting patients at the Center of Value-Based Care. Clin Cancer Res 23(16):4545–4549. https://doi.org/10.1158/1078-0432.CCR-17-1609 CrossRefPubMed

43.

Aranda S, Whittaker K (2018) Patient out-of-pocket expenses. Asia Pac J Clin Oncol 14(S7):50–90. https://doi.org/10.1111/ajco.13088

44.

Monterosso L, Platt V, Krishnasamy M, Yates P, Bulsara C (2016) The cancer nurse coordinator service in Western Australia: perspectives of specialist cancer nurse coordinators. Aust J Adv Nurs 34(2):16

Titel: How communication between cancer patients and their specialists affect the quality and cost of cancer care
verfasst von: Neli Slavova-Azmanova
Jade C. Newton
Harry Hohnen
Claire E. Johnson
Christobel Saunders
Publikationsdatum: 29.03.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: Supportive Care in Cancer / Ausgabe 12/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-019-04761-w

Neu im Fachgebiet Onkologie

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Blutdrucksenkung könnte Uterusmyome verhindern

21.05.2024 Krebsvorsorge in der Gynäkologie Nachrichten

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

How communication between cancer patients and their specialists affect the quality and cost of cancer care

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

CAR-M-Zellen: Warten auf das große Fressen

Blutdrucksenkung könnte Uterusmyome verhindern

Update Onkologie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2019

Social disparities and symptom burden in populations with advanced cancer: specialist palliative care providers’ perspectives

The Dyadic Communicative Resilience Scale (DCRS): scale development, reliability, and validity

What symptoms are important to patients? Developing a symptom burden measure for women with breast cancer

Effects of exercise on inflammation in patients receiving chemotherapy: a nationwide NCORP randomized clinical trial

Sexual quality of life after the treatment of gynecologic cancer: what women want

Positive effects of acupressure bands combined with relaxation music/instructions on patients most at risk for chemotherapy-induced nausea

Neu im Fachgebiet Onkologie

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

CAR-M-Zellen: Warten auf das große Fressen

Blutdrucksenkung könnte Uterusmyome verhindern

Update Onkologie